nccos great lakes mussel watch: contamination monitoring ......summary of chemical concentrations in...
TRANSCRIPT
Ed Johnson1, Annie Jacob2 ,Kimani Kimbrough1, Erik Davenport1and Michael Edwards1 1National Centers for Coastal Ocean Science, National Oceanic and Atmospheric Administration, Maryland
2Consolidated Safety Services-Dynamac, Virginia
Introduction Under the President’s Great Lakes Restoration Initiative
launched in 2009, NCCOS Mussel Watch Program (MWP)
expanded and enhanced its monitoring efforts by adding
numerous sites within highly impacted areas and conducting
targeted monitoring and contamination assessments using
newer techniques and approaches in partnership with
universities and other federal agencies.
Enhanced efforts include the:
Deployment of caged mussels where extant mussel beds
are not found.
Incorporation of effects- based monitoring (cellular
biomarkers, genomics and metabolomics) to link
contaminant exposure to bioeffects.
Deployment of additional matrices such as passive
samplers and Hester Dendy along with caged mussels.
Assessment of contaminants of emerging concern (CECs).
Results
Methods Dreissenid mussels are harvested from the harbor
breakwater and deployed in cages at pre-determined
stations in Areas of Concern (AOCs) of interest.
Mussels are collected after 5 -10 weeks of deployment and
analyzed for relevant contaminants.
Conclusions and Next Steps Caged dreissenid mussels are a robust tool in identifying localized areas of contamination within an AOC.
Offshore and nearshore contaminant measurements bring perspective to localized contamination assessments in river
and harbor sites.
Effects-based monitoring and surveillance approaches will be used to support traditional contaminant monitoring.
Decades of MWP monitoring data will be modeled to determine baseline concentrations.
NCCOS Great Lakes Mussel Watch: Contamination Monitoring and Assessment for
Restoration of the Great Lakes
Figure 1. Basin-wide map of offshore (),nearshore (), river-harbor()
sites. Callout boxes show locations where intensive assessments were
conducted to support monitoring and modeling efforts.
Figure 2. Caged mussels are deployed in minnow traps and placed on
cinder blocks or a mooring that suspends them approximately 12 inches
off the sediment. Mussels have been deployed with Hester-Dendy,
Polyethylene Devices (PEDs), and Polar Organic Chemical Integrative
Samplers (POCIS).
Figure 3. Box and whisker plots of contaminant concentrations in mussel tissue
from MWP river-harbor sites in the Great Lakes obtained from 2009-2015. The
contaminant concentrations were grouped into Low, Medium and High using k-
means cluster analysis. Green line indicates the basin-wide mean concentration
in mussels from offshore and nearshore sites.
Figure 5. Summary of chemical concentrations in mussels (PCB, PAH and PBDE concentrations are in ng/g dry
wt and MeHg concentrations are in ug/g dry wt) located in the Niagara River and seven tributaries, relative to the
basin-wide cluster analysis (Fig. 3) obtained in 2014. Red triangles relate to the locations shown in inset maps.
Figure 6. Proportion of measured CEC detected in
mussels located in the Niagara River and seven of
its tributaries.
1,2,3,7,8,9-HXCDF Diazepam Oxolinic Acid
1,7-Dimethylxanthine Digoxigenin Oxycodone
4-Epianhydrochlortetracycline
[EACTC] Digoxin Oxytetracycline [OTC]
4-Epianhydrotetracycline [EATC] Doxorubicin Paroxetine
4-Epichlortetracycline [ECTC] Doxycycline Penicillin G
4-Epioxytetracycline [EOTC] Drospirenone Penicillin V
4-Epitetracycline [ETC] Enalapril Prednisolone
Acetaminophen Flumequine Prednisone
Alprazolam Fluocinonide Promethazine
Amlodipine Fluticasone propionate Propoxyphene
Amphetamine Furosemide Ranitidine
Amsacrine Glipizide Rosuvastatin
Anhydrochlortetracycline [ACTC] Glyburide Roxithromycin
Anhydrotetracycline [ATC] Hydrochlorothiazide Sarafloxacin
Atorvastatin Hydrocodone Simvastatin
Azathioprine Hydrocortisone Sulfachloropyridazine
Benzoylecgonine Ibuprofen Sulfadiazine
Benztropine Iopamidol Sulfadimethoxine
beta-HBCDD Isochlortetracycline
[ICTC] Sulfamerazine
Betamethasone Lincomycin Sulfamethazine
Bisphenol A Lomefloxacin Sulfamethizole
Caffeine Medroxyprogesterone
Acetate Sulfamethoxazole
Carbadox Melphalan Sulfanilamide
Carbamazepine Meprobamate Sulfathiazole
Cefotaxime Metformin Tamoxifen
Chlortetracycline [CTC] Methylprednisolone Teniposide
Cimetidine Metoprolol Tetracycline [TC]
Clarithromycin Metronidazole Theophylline
Clinafloxacin Minocycline Thiabendazole
Clonidine Moxifloxacin Trenbolone
Cloxacillin Naproxen Trenbolone acetate
Codeine Norfloxacin Triclosan
Colchicine Norfluoxetine Tylosin
Cotinine Norgestimate Valsartan
Cyclophosphamide Ofloxacin Warfarin
Daunorubicin Ormetoprim Zidovudine
Dehydronifedipine Oxacillin
Demeclocycline Oxazepam
Diatrizoic acid
Figure 7. Proportion of measured CECs present in mussels
(2014) located in the Niagara River and seven tributaries.
Table 1. List of CECs not detected in mussels located in Niagara
River and seven of its tributaries.
PAH PCB PBDE MeHg
Figure 4. For each contaminant, the associated pie chart summarizes the site-type; offshore (dark green),
nearshore (light green), and river-harbor (where 3 shades of blue relate to clustered concentrations in Fig 3).
PA
H C
on
cen
trati
on
(n
g/g
dry
wt)
0
20000
40000
60000
80000
PC
B C
on
ce
ntr
ati
on
(n
g/g
dry
wt)
0
2000
4000
6000
8000
Harbor/River Sites
Low Medium High
PB
DE
Co
nc
en
tra
tio
n
(n
g/g
dry
wt)
0
50
100
150
200
250
Harbor/River Sites
Low Medium High
Me
Hg
Co
nc
en
tra
tio
n
(u
g/g
dry
wt)
0.00
0.05
0.10
0.15
0.20
0.25
Proportion present
0.0 0.2 0.4 0.6 0.8 1.0
1,2,3,4,6,7,8-HPCDD2,3,7,8-TCDF
4-NPDEET
NP1EONP2EOOCDD
1,2,3,4,6,7,8-HPCDF2,3,7,8-TCDD
SertralineAmitriptyline
Etoposide2,3,4,7,8-PECDF
OCDFDiphenhydramine
1,2,3,7,8,9-HXCDDTriclocarban
1,2,3,4,7,8-HXCDF1,2,3,6,7,8-HXCDD
1,2,3,7,8-PECDDCitalopram
10-hydroxy-amitriptylineVerapamil
1,2,3,6,7,8-HXCDF1,2,3,7,8-PECDF
2,3,4,6,7,8-HXCDF1,2,3,4,7,8,9-HPCDF
1,2,3,4,7,8-HXCDDClotrimazole
Diltiazemalpha-HBCDD
AzithromycinFluoxetine
CocaineEnrofloxacinMiconazolePropranololVenlafaxine
DesmethyldiltiazemTriamterene
Trimethoprim2-Hydroxy-ibuprofen
4n-OPBusulfan
Erythromycin-H2Ogamma-HBCDD
NorverapamilVirginiamycin M1
AlbuterolAtenolol
CiprofloxacinGemfibrozil